Skip to main content
MF

Molecular Forecaster

Molecular Forecaster provides end‑to‑end small‑molecule drug discovery services, combining proprietary CADD software, expert consulting, and a collaborative ecosystem of partner providers. Their platform supports hit discovery, hit‑to‑lead, and lead optimization, helping clients expand capacity, improve research efficiency, and accelerate project timelines.

Montreal, QuebecFounded 2010202K+ followers
Updated 1 month ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Pharmaceutical research teams often face bottlenecks in small‑molecule drug design due to limited computational resources, fragmented toolsets, and insufficient access to specialized expertise, which slows hit discovery and lead optimization.

Solution

Molecular Forecaster offers an end‑to‑end platform that combines proprietary computer‑aided drug design (CADD) software with expert consulting and a collaborative ecosystem of partner providers. The platform delivers tailored tools for hit discovery, hit‑to‑lead, and lead optimization, enabling teams to expand capacity, improve research efficiency, and shorten project timelines. By integrating software, on‑demand CADD support, and direct access to specialists, the service helps pharmaceutical companies make data‑driven decisions throughout the design workflow. The ecosystem also connects users with additional service providers to broaden capabilities and streamline project execution.

Target Audience

Primary customers are pharmaceutical and biotech companies, as well as contract research organizations, that need comprehensive small‑molecule design capabilities and expert support to accelerate their drug discovery programs.

Features

  • Proprietary CADD suite that automates molecular modeling, virtual screening, and structure‑based design
  • Customizable workflows for hit discovery, hit‑to‑lead, and lead optimization phases
  • On‑demand consulting from experienced medicinal chemists and computational scientists
  • Integrated collaboration network that links users with vetted partner service providers
  • Cloud‑based platform that scales computational capacity on demand
  • Reporting dashboards that consolidate design metrics and project progress for rapid decision‑making
This profile is AI-generated and may contain inaccuracies.